Main useUsed for selected inflammatory conditions such as atopic dermatitis and severe asthma, depending on formulation.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- デュピクセント皮下注300mg／200mg ペン・シリンジ
- Brand
- Dupixent
- Generic name
- Dupilumab
- Japanese generic name
- デュピルマブ
- Chinese name
- 度普利尤单抗
- Marketing authorization holder
- サノフィ株式会社
- Strengths
- 200 mg / 300 mg
- Dosage form
- SC pen / syringe
- Therapeutic area
- Immunologie
- Regulatory status
- Rx
- Label updated
- 2026-03-23
- TOKYO MEDI verified
- 2026-09-22
Source officielle
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.